Podcasts about peritoneal

This mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This third episode highlights the Hepato-Pancreato-Biliary cancer operative standard.Hosts:Eliza W. Beal, MD, FACS (X: @ElizaWBealMD) is a Hepato-Pancreato-Biliary surgeon at the Barbara Ann Karmanos Cancer Institute in Detroit. She is also an associate professor of Oncology and Surgery at Wayne State University School of Medicine.Morgan Jackson, MD is a general surgery resident at the Detroit Medical Center and Wayne State University in Detroit, MI.Daniel Nelson, MD, FACS, FSSO (X: @DWNelsonHPB) is a Hepato-Pancreato-Biliary surgeon at the University of Tennessee Health Science Center - Chattanooga.Hop Sanderson Tran Cao, MD, FACS (X: @HopSTranCao) is a Hepato-Pancreato-Biliary surgeon at MD Anderson Cancer Center. Guest:Alice Wei, MD is a Hepato-Pancreato-Biliary surgeon at Memorial Sloan Kettering and associate professor of surgery at Weill Cornell School of Medicine. Dr. Wei contributed to the development of the operative standards for HPB surgery. Learning Objectives: The goals of this podcast are to provide education about the standards, generate discussion, and offer technical pearls to both oncologic specialists and general surgeons, to all of whom these standards apply. In this podcast we discuss the operative standards for liver resection for hepatocellular carcinoma, which includes that the surgeon should: (1) perform a thorough inspection of the liver and abdomen, either laparoscopically or open, including performing liver ultrasound, and (2) should resect all lesions to macroscopically negative margins, preferably with an anatomic resection. Our guest Dr. Wei also provides technical tips, pearls for improving skills performing and interpreting liver ultrasound, and discusses the role of lymphadenectomy in patients with hepatocellular carcinoma. References: Operative Standards for Cancer Surgery, Volume 3: Sarcoma, Adrenal, Neuroendocrine, Peritoneal, Urothelial, Hepatobiliary https://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewOBGYN Oral Board Review Coures: https://behindtheknife.org/course/obgyn-oral-board-reviewEPA Playbook: https://behindtheknife.org/course/epa-playbookSurgical Instrument Flashcards: https://behindtheknife.org/course/surgical-instrument-flashcardsABSITE Review: https://behindtheknife.org/course/absite-2026-exam-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of SurgOnc Today, key components of the recently launched Patient Manifesto will be discussed by appendix cancer medical experts and advocacy organizations. The goal of the podcast is to educate the medical community and our patient community on this manifesto and how we can work together to advance these key initiatives.

ASN Kidney Translation Podcast episode covers advances in peritoneal dialysis: genetic determinants of ultrafiltration (JASN), fungus-derived ergothioneine depletion in PD (K360), and a survey of PD use in the Veterans Health Administration (CJASN).

Guest Dr. Jeffrey Perl joins host Dr. Tushar Chopra to explore strategies to prevent peritoneal dialysis infections, address gaps in practice, review infection trends, and discuss opportunities for progress through collaboration and team-based care.

Guest Dr. Jeffrey Perl joins host Dr. Tushar Chopra to explore strategies to prevent peritoneal dialysis infections, address gaps in practice, review infection trends, and discuss opportunities for progress through collaboration and team-based care.

In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about innovations in regional cancer therapies. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms River and Brick, New Jersey. He was joined by: Anthony Scholer, MD, FACS, FSSO, a surgical oncologist specializing in hepatobiliary surgery, at Hackensack Meridian Medical Group and Jersey Shore University Medical Center in Neptune, New Jersey Benjamin Jon Golas, MD, FACS, regional chief of Surgical Oncology for Hackensack Meridian Health's Central Region, surgical director of Oncology Services at Jersey Shore University Medical Center, vice chair of Surgery at Jersey Shore University Medical Center Cancer Surgery, and an associate professor of surgery at the Hackensack Meridian School of Medicine in Neptune and Edison, New Jersey Eric Pletcher, MD, a surgeon specializing in Complex General Surgical Oncology at Hackensack Meridian JFK University Medical Center in Edison Drs Tiesi, Scholer, Golas, and Pletcher chatted about the use of pressurized intraperitoneal aerosolized chemotherapy (PIPAC), a minimally invasive regional cancer therapy designed for patients with peritoneal metastases or primary peritoneal cancers. The experts explained that this laparoscopic approach overcomes several limitations of traditional systemic treatments by delivering aerosolized chemotherapy in fine droplets under high pressure into the peritoneal cavity. This process ensures uniform drug distribution and enhanced tissue penetration, allowing for efficacy with lower systemic drug concentrations, they noted.  PIPAC candidates typically present with unresectable or recurrent disease, or symptomatic malignant ascites, and should have an ECOG performance status between 0 and 2, they elaborated. The procedure, which is repeatable every 4 to 6 weeks, includes diagnostic laparoscopy, quantification of the peritoneal carcinomatosis index, and serial biopsies to assess treatment response. They emphasized that PIPAC has a favorable safety profile, with low 30-day mortality rates and minimal grade 3/4 adverse effects reported in clinical trials. Additionally, they stated that clinical data indicate high pathologic response rates and the potential for disease downstaging, enabling some patients who were initially deemed unresectable to become eligible for subsequent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Of note, the experts reported that PIPAC is designed to be integrated seamlessly with concurrent systemic therapy.

In this episode of SurgOnc Today, SSO Peritoneal Surface Malignancy Disease Site Working Group members Dr. Alissa Greenbaum and Dr. Omar Llaguna moderate a discussion with Dr. Maheswari Senthil of UC Irvine and Dr. Richard Alexander of the Rutgers Cancer Institute of New Jersey to dive deep into the history of the development of regional therapies such as HIPEC and PIPAC in the United States. The expert discussants answer tough questions regarding the ethical considerations of modern clinical trials and the implementation of experimental therapies into practice.

This podcast discuss findings from a prospective cohort of patients with severe and symptomatic ESKD requiring an urgent start of HD or PD owing to uremic syndrome, where both modalities offered similar outcomes.

In a conversation with CancerNetwork®, Benjamin Golas, MD, spoke about the current treatment landscape for patients with peritoneal carcinomatosis, discussing how the use of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) may offer improvements in clinical outcomes. Golas is the chief of Surgical Oncology of the Central Region for Hackensack Meridian Health. According to Golas, standard therapeutic approaches include combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), which may cause collateral damage to healthy tissue while eliciting toxicities such as nausea, vomiting, and bone marrow suppression. Additionally, certain surgical procedures may last up to 14 hours and confer an extensive morbidity profile, thereby increasing complication rates. Golas described how PIPAC, a minimally invasive laparoscopic technique, may help avoid pain and other adverse effects associated with surgery while facilitating more direct delivery of chemotherapy in the peritoneal cavity. He noted that treatment with PIPAC typically takes 45 minutes to an hour, allowing some patients to return home on the same day of the procedure.  Although clinicians are still learning the correct indications for PIPAC, Golas stated that any patient with peritoneal carcinomatosis should be a candidate to receive treatment with this strategy. Furthermore, he described how the next steps for improving outcomes in this population include finding new ways to incorporate PIPAC into more extensive treatment plans for patients.  “PIPAC is a new treatment and a new potential option that doesn't replace systemic chemotherapy, but I do think it can work in conjunction with systemic chemotherapy. We can offer this bimodal approach where we're directly treating the peritoneal disease and offering [intravenous] chemotherapy,” Golas stated. “We clearly have a long way to go in terms of clinical trials and learning what the best ways are to use this. But there are patients out there who will benefit from that, so I think referral to a center that focuses and has expertise in PIPAC for patients with peritoneal carcinomatosis is critical.”

We're bringing the heat as Dr. Laura Enomoto, Dr. Melanie Ongchin and Dr. Alissa Greenbaum discuss key highlights and updates in Peritoneal Surface Malignancy and HIPEC presented at the 2025 SSO Annual Meeting. This episode explores evolving evidence, multidisciplinary approaches, and clinical trials shaping the future of care in this complex disease space

Appendiceal neoplasms present with peritoneal carcinomatosis and despite aggressive CRS/HIPEC, often recur and are chemotherapy resistant. In this Colorectal DSWG SSO sponsored podcast episode, we discuss an overview of the recent publication of "Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis with GNAS Mutations" by Dr. Lowy's research lab at UCSD. The authors treated 16 patients in this Phase 2 study of oral Palbociclib in recurrent appendiceal adenocarcinoma patients and identified excellent treatment and long-term response with 13/16 of patients treated having reduction in CEA and excellent survival (median FU of 17.6 months, OS not reached). Dr Lowy provides informative background, study details and discusses next steps for this novel treatment approach. A link to the paper in question is https://pubmed.ncbi.nlm.nih.gov/39413348/

Data from nearly 16,000 French peritoneal dialysis (PD) patients were analyzed in this large observational study, to understand factors influencing transfers to hemodialysis for different reasons.

In this episode of SurgOnc Today®, Dr. Sinziana Dumitra discusses the evaluation and management of patients with peritoneal metastases from MSI-high colorectal cancer with Dr. Joshua Leinwand and Dr. Zachary Brown, including the role of HIPEC, immunotherapy, and differences in clinical characteristics and outcomes compared with microsatellite-stable disease.

Speaking of SurgOnc has a new home! New episodes can now be found under the Society of Surgical Oncology's podcast, SurgOnc Today®, available on all major podcast platforms. Subscribe today to receive updates on new episode releases. In this new episode of the ASO Episode Series of SurgOnc Today® (previously Speaking of SurgOnc), Dr. Rick Greene discusses with Dr. Michael Offin the clinicopathologic characteristics and outcomes of a large prospective cohort of well-differentiated papillary peritoneal mesothelial tumors, as reported in their article, "Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors."

Because of medical advances, kidney failure is no longer a death sentence. Today, those with kidney failure have treatment options like dialysis and kidney transplantation. Unfortunately, many aren't aware that home hemodialysis or peritoneal dialysis treatments are available. What is peritoneal dialysis and who can benefit from it? Today, Britney Dickerson, dialysis patient, and Jenny Wilson, Davita's regional director of home dialysis in New York City, are here to break it down. Jennie Wilson, MSN, RN has been working in Home Dialysis for over a decade and currently oversees several centers in the New York Metro Area that provide training and care to home dialysis patients. Her interest in population health and healthy equity has led to her passion for educating patients on their dialysis modality options. She has partnered with the National Kidney Foundation on various projects to share the clinical and lifestyle benefits of home dialysis. Brittany Dickerson- I am a dedicated mother, motivational speaker, and compassionate life coach living with Polycystic Kidney Disease (PKD). I use my kidney failure battle to educate and help others regarding kidney disease and transplantation. My personal journey has fueled my passion for helping others navigate life's challenges with courage and grace. Through partnership with the National Kidney Foundation, I have had the opportunity to mentor others and to be a guest for the National Kidney Foundation Podcast channel. My dedication to kidney awareness has led me to pursue becoming a National Kidney Foundation Advocate. I use my voice to spread my powerful message of perseverance and hope. My goal is to continue making an impact on individuals facing adversity, offering guidance, support, and being a shining example of strength in the face of hardship.    Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

This Podcast discusses a study on the effect of fluid overload-related hospitalizations on survival in PD patients. The study found that patients hospitalized due to fluid overload within the first 12 months of starting PD had higher mortality rates.

This episode highlights a study on the time-varying effect of assistance on risk of PD cessation using data from the RDPLF of 15675 incident PD patients. Patients treated with assisted PD had a greater risk of death and a lower risk of transfer to HD.

This latest episode of the Global Kidney Care Podcast is an effort of the ISN, ISPD, and Arbor Research Collaborative for Health (the coordinating center for the DOPPS family of studies). This episode is focused on PDOPPS, our international study of practice patterns and outcomes of peritoneal dialysis patients. The conversation is led by Roberto Pecoits-Filho, DOPPS Program Scientific Director and is joined by the president of the ISPD Edwina Brown from the Imperial College Renal & Transplant Centre, Jenny Shen from the Harbor-UCLA Medical Center and Jeffrey Perl from St Michael's Hospital in Toronto and the Principal Investigator of PDOPPS.

Live Nursing Review with Regina MSN, RN! Every Monday & Wednesday we are live. LIKE, FOLLOW, & SUB @ReMarNurse for more.     ► Sign-up for ReMar Nurse University - ReMarNurse.com/RNU ► 30% Discount on NCLEX V2 - http://www.ReMarNurse.com ► Get Quick Facts Next Gen - https://bit.ly/QF-NGN ► Subscribe Now - http://bit.ly/ReMar-Subscription ► GET THE PODCAST: https://remarnurse.podbean.com/ ► WATCH LESSONS: http://bit.ly/ReMarNCLEXLectures/ ► FOLLOW ReMar on Instagram: https://www.instagram.com/ReMarNurse/ ► LIKE ReMar on Facebook: https://www.facebook.com/ReMarReview/   Quick Facts for NCLEX Next Gen Study Guide here - https://bit.ly/QF-NGN Study with Professor Regina MSN, RN every Monday as you prepare for NCLEX Next Gen.   ReMar Review features weekly NCLEX review questions and lectures from Regina M. Callion MSN, RN. ReMar is the #1 content-based NCLEX review and has helped thousands of repeat testers pass NCLEX with a 99.2% student success rate! ReMar focuses on 100% core nursing content and as a result, has the best review to help nursing students to pass boards - fast!

Today, we dive into the world of kidney replacement therapy with a focus on two primary modalities: "Hemodialysis vs. Peritoneal Dialysis: Understanding the Differences and Choosing the Right Option." We'll explore the distinct characteristics, benefits, and considerations of hemodialysis and peritoneal dialysis, helping individuals with kidney failure to make informed decisions about their treatment options. _ The Kidney Zone Podcast with Dr. Mo Welcome to the Kidney Zone, where we will dive deep into the fascinating world of our body's remarkable filters. Get ready to unlock the secrets of the kidneys and transplantation as we travel through their pathways, uncovering vital tips, insightful knowledge, and practical advice to keep our kidneys healthy. Whether you're a patient with kidney disease, a medical professional, or simply curious about the kidneys, this is the place for you. _ Follow Along on Social Media: Facebook: https://www.facebook.com/Dr.Mo.Page Instagram: https://www.instagram.com/dr.mo.ibrahim/ Twitter: https://twitter.com/drmoibrahim TikTok: https://www.tiktok.com/@dr.mo.ibrahim _ Dr. Mo Ibrahim is an assistant professor of kidney transplantation at the University of Maryland, Baltimore. He completed his clinical transplant nephrology fellowship at Washington University in 2022. Originally from Cairo, he pursued a physician/scientist career, conducting research at Duke University from 2012 to 2019. He has authored 70+ journal articles, given a TEDx talk, and holds 5 patents. Currently finishing his PhD at Erasmus University, he drives international collaborations to advance medical technology and improve medical monitoring. _ DISCLAIMER The content of this episode is intended for informational purposes only and is not to be considered medical advice. The information presented here is not meant to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare professional or your doctor before making any healthcare decisions or starting any treatment regimen. Individual medical situations can vary, and only a licensed healthcare provider can offer personalized advice tailored to your specific needs. The creators of this episode are not responsible for any actions taken based on the information provided herein. Any reliance on the content of this episode is at your own risk. If you have any medical concerns or questions, please seek guidance from a medical professional promptly. Remember that medical knowledge and practices can evolve over time, and new information may become available after the creation of this episode. Therefore, it is essential to stay up-to-date with the latest medical research and consult with your healthcare provider to ensure the best possible care for your health.

Welcome to an insightful episode of Diary of a Kidney Warrior podcast where Kidney Warriors and Health Professionals share their experiences and knowledge about kidney disease. This episode, hosted by Dee Moore, a dedicated kidney health advocate and kidney warrior herself, features Dr. Lavanya Kamesh, a Consultant Nephrologist from Birmingham, England with a 15-year specialisation in Peritoneal Dialysis. This episode dives deep into the nuances of Peritoneal Dialysis, dissecting how it operates and who it might suit. Dee Moore shares her personal experiences with peritoneal dialysis. Listeners are also offered an in-depth understanding of the contents and the significance of the peritoneal dialysis fluid. Dr. Kamesh provides an expert perspective, emphasising the benefits of peritoneal dialysis, such as its ability to preserve a patient's independence. Additionally, the episode elaborates on the importance of informed decision-making and patient choice in determining the type of dialysis one chooses. The episode also delves into challenges faced during peritoneal dialysis, such as infection risks and tube malfunctions, and the measures in place to minimise these risks. Another aspect discussed is the concept of 'self-care', emphasising the patient's role in taking full ownership of their health. Everyday practicalities of peritoneal dialysis, like the types of bags used and storage of dialysis supplies, are also discussed. The episode concludes on an optimistic note, providing practical advice and outlining how patients can benefit from peritoneal dialysis while managing its associated challenges. Tune in to learn, be inspired, and gain valuable insights.   For updates and more, follow Dee Moore on:   Instagram: www.instagram.com/diaryofakidneywarrior  Facebook: www.facebook.com/diaryofakidneywarrior  Twitter: www.twitter.com/diaryofakidneyw  Tik Tok: @diaryofakidneywarrior  Youtube: https://www.youtube.com/channel/UChGUfib7lu9eKENlLJ6lafw Pinterest: https://www.pinterest.co.uk/diaryofakidneywarrior/   Join the Diary of a Kidney Warrior Family Mailing list to get new episode reminders, episode links, Vlogs, newsletters and more!   diaryofakidneywarrior.getform.com/rjv47    Follow Kidney Care UK   •           Website: www.kidneycarekuk.org •           Email: info@kidneycareuk.org •           Tel: 01420 541 424 •           Facebook: www.facebook.com/kidneycareuk.org •           Instagram: @kidneycareuk •           YouTube: https://www.youtube.com/channel/UCeqQTdAsEzXphqjHVtcTD-A   To sign up to receive the Kidney Matters Quarterly Magazine Email: info@kidneycareuk.org

When the kidneys fail, the hard decision becomes which dialysis modality should you choose? Today we will discuss the dialysis options. We will explore the two primary modalities: Hemodialysis and Peritoneal Dialysis. We will understand differences between these treatments, benefits, and considerations for individuals navigating the challenging terrain of kidney disease. _ The Kidney Zone Podcast with Dr. Mo Welcome to the Kidney Zone, where we will dive deep into the fascinating world of our body's remarkable filters. Get ready to unlock the secrets of the kidneys and transplantation as we travel through their pathways, uncovering vital tips, insightful knowledge, and practical advice to keep our kidneys healthy. Whether you're a patient with kidney disease, a medical professional, or simply curious about the kidneys, this is the place for you. _ Follow Along on Social Media: Facebook: https://www.facebook.com/Dr.Mo.Page Instagram: https://www.instagram.com/dr.mo.ibrahim/ Twitter: https://twitter.com/drmoibrahim TikTok: https://www.tiktok.com/@dr.mo.ibrahim _ Dr. Mo Ibrahim is an assistant professor of kidney transplantation at the University of Maryland, Baltimore. He completed his clinical transplant nephrology fellowship at Washington University in 2022. Originally from Cairo, he pursued a physician/scientist career, conducting research at Duke University from 2012 to 2019. He has authored 70+ journal articles, given a TEDx talk, and holds 5 patents. Currently finishing his PhD at Erasmus University, he drives international collaborations to advance medical technology and improve medical monitoring. _ DISCLAIMER The content of this episode is intended for informational purposes only and is not to be considered medical advice. The information presented here is not meant to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare professional or your doctor before making any healthcare decisions or starting any treatment regimen. Individual medical situations can vary, and only a licensed healthcare provider can offer personalized advice tailored to your specific needs. The creators of this episode are not responsible for any actions taken based on the information provided herein. Any reliance on the content of this episode is at your own risk. If you have any medical concerns or questions, please seek guidance from a medical professional promptly. Remember that medical knowledge and practices can evolve over time, and new information may become available after the creation of this episode. Therefore, it is essential to stay up-to-date with the latest medical research and consult with your healthcare provider to ensure the best possible care for your health.

Survey findings demonstrate that the adjustments made by the dialysis units during the peak of the pandemic were effective in maneuvering the challenges faced by our patients during the COVID-19 pandemic while providing high-quality medical care.

Este podcast está presentado por los médicos neonatólogos Dani de Luis Rosell, Elena Itriago, y Carolina Michel; nuestro invitado especial, Gonzalo Solís García, neonatólogo y primer autor de uno de los artículos que presentamos hoy, quien nos comparte su perspectiva como investigador.  Te saluda tu anfitriona, Maria Flores Cordova, médico residente de pediatría. Creado originalmente por el Dr. Ben Courchia y la Dra. Daphna Yasova Barbeau. No dudes en enviarnos preguntas, comentarios o sugerencias a nuestro correo electrónico: nicupodcast@gmail.comLos artículos que se tratan en el episodio de hoy están listados aquí: Viral Infections and Neonatal Necrotizing Enterocolitis: A Meta-analysis.Mani S, Hazra S, Hagan J, Sisson A, Nair J, Pammi M.Pediatrics. 2023 Jul 1;152(1):e2022060876. doi: 10.1542/peds.2022-060876.PMID: 37293714Factors associated with the increased incidence of necrotising enterocolitis in extremely preterm infants in Sweden between two population-based national cohorts (2004-2007 vs 2014-2016).Challis P, Källén K, Björklund L, Elfvin A, Farooqi A, Håkansson S, Ley D, Norman M, Normann E, Serenius F, Sävman K, Hellström-Westas L, Um-Bergström P, Ådén U, Abrahamsson T, Domellöf M.Arch Dis Child Fetal Neonatal Ed. 2023 Oct 3:fetalneonatal-2023-325784. doi: 10.1136/archdischild-2023-325784. Online ahead of print.PMID: 37788898Laparotomy versus Peritoneal Drainage as Primary Treatment for Surgical Necrotizing Enterocolitis or Spontaneous Intestinal Perforation in Preterm Neonates: A Systematic Review and Meta-Analysis.Solis-Garcia G, Pierro A, Jasani B.Children (Basel). 2023 Jul 6;10(7):1170. doi: 10.3390/children10071170.PMID: 37508667  Bienvenidos a La Incubadora: una conversación sobre neonatología y medicina basada en evidencia. Nuestros episodios ofrecen la dosis ideal (en mg/kg) de los más recientes avances para el neonato y para las increíbles personas que forman parte de la medicina neonatal. Soy tu host, Maria Flores Cordova, MD. Presentado por los Neonatólogos Elena Itriago MD, Dani de Luis Rosell MD, Carolina Michel MD, las futuras doctoras Marla Fortoul, Valentina Giraldo, Laura Molina. Creado originalmente por Ben Courchia MD y Daphna Yasova Barbeau MD http://www.the-incubator.org

Direct Peritoneal Resuscitation!  We're not just dumping fluids into the open abdomen.  What is DPR?  Why do it?  Who should get it?  Does it work? Come try and stay awake for some basic science talk before then learning all about why you should consider adopting DPR into your Trauma/EGS practice? Join Drs. Cobler-Lichter, Kwon, Meizoso, Urréchaga, and Rattan as they guide you through all this and more!  Hosts: Michael Cobler-Lichter, MD, PGY2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (twitter) Eva Urrechaga, MD, PGY6/R4: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @urrechisme (twitter) Eugenia Kwon, MD, Trauma/Surgical Critical Care Fellow: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 3 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @jpmeizoso (twitter) Rishi Rattan, MD, Attending Surgeon in Trauma/Critical Care, 7 years in practice Legacy Emanuel Medical Center @DrRishiRattan (twitter) Learning Objectives: - State the proposed benefits of DPR - Identify who can benefit from DPR - Demonstrate the proper way to set up a DPR circuit - Discuss the proposed basic science mechanism for DPR's efficacy Quick Hits: 1.      Consider DPR in all your open abdomens in EGS/Trauma.  You never know when you're going to be able to close some of these patients. 2.     The principal of DPR is to allow the fluid to dwell in the abdomen as long as possible.  Keep the catheter deep and don't put holes in your dressing. 3.     DPR is ideal for patients with packing, who are in discontinuity, and for fresh anastomoses.  These will only benefit from DPR, not be harmed by it.  4.     Make sure these patients are receiving hourly I/Os.  Nursing by-in is huge for this procedure. 5.     DPR is associated with higher rates of fascial closure, reduces inflammation, and improves blood flow to the abdomen. References Ribeiro-Junior MAF, Cássia Tiemi Kawase Costa, de Souza Augusto S, et al. The role of direct peritoneal resuscitation in the treatment of hemorrhagic shock after trauma and in emergency acute care surgery: a systematic review. Eur J Trauma Emerg Surg. Published online November 13, 2021. doi:10.1007/s00068-021-01821-x Smith JW, Garrison RN, Matheson PJ, Franklin GA, Harbrecht BG, Richardson JD. Direct Peritoneal Resuscitation Accelerates Primary Abdominal Wall Closure after Damage Control Surgery. J Am Coll Surg. 2010;210(5):658-667. doi:10.1016/j.jamcollsurg.2010.01.014 Smith JW, Neal Garrison R, Matheson PJ, et al. Adjunctive treatment of abdominal catastrophes and sepsis with direct peritoneal resuscitation: indications for use in acute care surgery. J Trauma Acute Care Surg. 2014;77(3):393-398; discussion 398-399. doi:10.1097/TA.0000000000000393 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episode here: https://behindtheknife.org/listen/

This week your MEM host Dr Cristina Cusu, renal registrar in Leicester, gives you a quick round down on common topics discussed around peritoneal dialysis. Enjoy listening. 

What complications should you watch our for in patients on peritoneal dialysis? Let this once elusive topic become your expertise! This episode was written by Dr. Shareef Akbari (Internal Medicine Resident) and reviewed by Dr. Bogdan Momciu (Nephrology) and Dr. Steven Montague (General Internal Medicine)Infographic by Dr. Caitlyn Vlasschaert (Internal Medicine Resident)Sound editing by Margaret Sun  (Internal Medicine Resident)Support the show

This session will review state of the art therapy for peritoneal mesothelioma. The discussion includes cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as well as systemic chemotherapy and immunotherapy. Edward Levine, MD, moderates this podcast and is Professor of Surgery and Chief, Surgical Oncology at Wake Forest University. Trang Nguyen, MD, is an Assistant Professor of Surgery at Indiana University and Sinziana Dumitra, MD, MSc, FRCSC, FSSO, is an Assistant Professor of Surgery at McGill University. 

Let's discuss the sheets of connective tissue in the abdominal cavity, aka the peritoneum. Let's explore how the folds of this membrane are called different things depending on how many folds there are, & how these folds form spaces……that us anatomists also name. In addition to the terminology, let's discuss the functions & clinical relevance of all these membranes, to justify knowing them. Terms covered this week: The peritoneum & the parietal & visceral iterations of this. Peritoneal fluid. The mesentery. The greater & lesser omentum. The greater & lesser sacs. Finally, what on earth is meant by retroperitoneal?

Show notes and links: https://www.chrisbeatcancer.com/how-nurse-carol-howard-healed-incurable-peritoneal-cancer/

Edwina Brown, Consultant Nephrologist at Imperial College Renal and Transplant Centre at Hammersmith Hospital, London, UK, and Honorary Professor of Renal Medicine at Imperial College London, UK, joins Jonathan to discuss how nephrologists can take a more person-centred approach to medical care and decision-making. Brown also details her goals as President of the International Society for Peritoneal Dialysis (ISPD), and how she wants it to become more inclusive. Use the following timestamps to navigate the topics discussed in this episode: (00:00)-Introduction (02:06)-A patient-centric approach in nephrology (03:51)-Brown's goals as President of the ISPD (07:27)-A 30,000-foot view of peritoneal dialysis (10:18)-Peritoneal dialysis from a global perspective (18:02)-Kidney failure in an aging population (23:07)-Controversies in nephrology and how they are being addressed (27:04)-End-of-life renal care and bereavement support (29:38)-The changing landscape of women in nephrology (33:12)-Brown's three wishes for the future of healthcare

In this panel episode recorded at SIR 2023, Drs. Stephen Hunt, Chuck Martin, and Gaurav Gadodia update us on current applications and future directions of augmented reality in interventional radiology. --- CHECK OUT OUR SPONSOR Medtronic Ellipsys Vascular Access System https://www.medtronic.com/ellipsys --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/voyqG5 --- SHOW NOTES Dr. Hunt explains the differences between virtual reality (VR), augmented reality (AR), and mixed reality (MR) since there is increasing levels of overlap between virtual and real worlds with each category . He notes that all three are being explored in surgical fields, especially orthopedics and neurosurgery. Within IR, augmented reality can be used to adjust images and subtract out respiratory motion, making biopsies and ablations safer and more effective. Dr. Hunt became interested in AR when his PIGI Lab at the University of Pennsylvania needed 3D models to access liver tumors in experimental mice. Additionally, AR is a useful tool for planning difficult procedures and teaching interventional procedures to trainees across the globe. Dr. Martin speaks about the intersection of medicine and industry. He directs research studies for Mediview, a company focused on bringing AR into medical imaging. Dr. Martin speaks about the important role that industry plays in commercializing an invention and getting it into operators' hands. As larger companies enter the AR space, accessibility and user interfaces will improve. Additionally, the shift towards AR product development can guide future FDA regulations. Dr. Gadodia's engineering background made him excited to enter the AR space as resident at the Cleveland Clinic. He highlights applications of AR in the non-academic setting. Using a headset could increase procedural efficiency and access to care. Finally, we discuss major shifts in industry and medicine that favor the increasing use of AR, such as industry's need for clinician input in product development, the multitude of startups working on the same issues, and the overarching goal of patient safety. --- RESOURCES Ep. 7- Lung Tumor Ablation with Dr. Stephen Hunt: https://www.backtable.com/shows/vi/podcasts/7/lung-tumor-ablation Ep. 53- International IR Volunteer Work with Dr. Stephen Hunt: https://www.backtable.com/shows/vi/podcasts/53/international-ir-volunteer-work Mediview: https://mediview.com/ Microsoft HoloLens: https://www.microsoft.com/en-us/hololens Penn Image-Guided Interventions (PIGI) Lab: https://www.med.upenn.edu/pigilab/

 March 24, 2023Mark, Ray, and Scott discuss FAQs:  Would you consider interposition of peritoneal flaps separately billable with a Prostatectomy/lymphadenectomy? “The peritoneum at the dome of the bladder was folded over itself and anchored to the front sides of the bladder”. There is no guidance out there that I can find for coding, other than studies that show it is more of a prophylactic procedure to prevent lymphoceles. I am currently not coding for it but was wanting a second opinion. With the PHE ending on 5/11/2023, but telehealth being extended thru 12/31/2024, what is the ruling on using non HIPAA compliant platforms such as Facetime?  Will this exception being going away with the 1135 waiver ending ?If a provider is only interested to do a post void residual (51798) and do not have a bladder scanner, can we use the ultrasound information (76857) as a post void residual and charge that way? Can you bill 76857 since the provider interprets the result of the post void residual?  Thank you.   Join The Urology Coding Compliance and Education Network and get started today!Pricing and More Information The Thriving Urology Practice Facebook Grouphttps://www.facebook.com/groups/ThrivingPractice  Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com 

Conversation with Travis Grotz, MD, surgical oncologist at Mayo Clinic who specializes in the treatment of peritoneal malignancies. Dr. Grotz serves on the Science Advisory Board of the Mesothelioma Applied Research Foundation. He is interviewed by Shannon Sinclair, RN, BSN, OCN, who serves as the patient services director at the Mesothelioma Applied Research Foundation. www.curemeso.org.

 Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Yasmin Lyons, DO and Lisa Rauh, MD discuss the best cervical, vulvar and vaginal cancer when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and joining a study group, visiting the SGO ConnectEd, meeting with your local radiation oncologist to discuss radiation in general and your individual patients managed, knowing landmark trials for prognostic factors (GOG 36), surgery for early-stage vulvar cancer, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO Collaboration during the SGO 2023 Annual Meeting During the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process, so please keep an eye for the following 2-hour session and three-day roundtable discussions when registering for the upcoming SGO 2023 Annual Meeting and be sure to sign up if interested in participating.                    2-hour ABOG and Stats Session and Three-day Roundtable DiscussionsFriday, March 24, 2023 | 1:00 – 4:00 pm | Special Interest Session III: Resident, Fellow, Candidate SessionBecoming an Expert: Board Certification Support Series: Present the partnership between the SGO Taskforce for Board Certification Support and the American Board of Obstetrics and Gynecology (ABOG) to demystify the logistics of the gynecologic oncology subspecialty certifying exam and the assessment and scoring process. Overview with ABOGStatistics Overview Three-day SGO Taskforce for Board Certification Support Roundtable Discussions – Part 1-3 | (7:15-8:15am)Target Audience: Candidates Taking Boards in April 2023The three-day roundtable will include discussions from taskforce facilitators covering hypothetical cases and case reviews with candidates that are in line with the sections of the certifying exam.Saturday March 25, 2023:  Ovarian, Peritoneal, Fallopian Tube Cancer (including Chemotherapy)]Sunday March 26, 2023: Uterine Malignancies: Endometrial Cancer, Sarcoma, GTD, otherMonday March 27, 2023: Cervical, Vulvar and Vaginal Cancer and Radiation TherapyResourcesClick here to access SGO ConnectEd to review additional resources on Cervical, Vulvar and Vaginal Cancer.NCCN guidelines, UpToDate, and GYOEDU.ORG.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Claire Hoppenot, MD and Alexander Melamed, MD discussing the best resources for Uterine Malignancies and GTD Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing for the ABOG Gynecology Oncology Certifying Exam.  They will help you reference the ABOG bulletin, resources on the SGO ConnectEd website, as well as relevant studies. In addition to this podcast, the taskforce will offer other informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO Collaboration during the SGO 2023 Annual MeetingDuring the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process, so please keep an eye for the following 2-hour session and three-day roundtable discussions when registering for the upcoming SGO 2023 Annual Meeting.2-hour ABOG and Stats Session and Three-day Roundtable DiscussionsSpecial Interest Session III: Resident, Fellow, Candidate SessionFriday, March 24, 2023 | 1:00 – 4:00 pmBecoming an Expert: Board Certification Support Series: Present the partnership between the SGO Taskforce for Board Certification Support and the American Board of Obstetrics and Gynecology (ABOG) to demystify the logistics of the gynecologic oncology subspecialty certifying exam and the assessment and scoring process. Overview with ABOG: 1 hour and 30 minutesStatistics Overview: 30 minutes  Three-day SGO Taskforce for Board Certification Support Roundtable Discussions – Part 1-3 | (7:15-8:15am)Target Audience: Candidates Taking Boards in April 2023The three-day roundtable will include discussions from taskforce facilitators covering hypothetical cases and case reviews with candidates that are in line with the sections of the certifying exam.Saturday March 25, 2023:  Ovarian, Peritoneal, Fallopian Tube Cancer (including Chemotherapy)]Sunday March 26, 2023: Uterine Malignancies: Endometrial Cancer, Sarcoma, GTD, otherMonday March 27, 2023: Cervical, Vulvar and Vaginal Cancer and Radiation TherapyResourcesClick here to access SGO ConnectEd to review additional resources on Uterine Malignancies and GTD Considerations.The ABOG Gynecology Oncology Exam bulletin, which has a comprehensive list of possible topics. As for some just general good places to focus as it gets closer to the time of the exam think about NCCN guidelines, UpToDate, and GYOEDU.ORG.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best ovarian cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the SGO Annual Meeting sessions to gain insight, knowing the FDA indications, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.   ABOG and SGO Collaboration during the SGO 2023 Annual Meeting During the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process, so please keep an eye for the following 2-hour session and three-day roundtable discussions when registering for the upcoming SGO 2023 Annual Meeting.2-hour ABOG and Stats Session and Three-day Roundtable DiscussionsSpecial Interest Session III: Resident, Fellow, Candidate SessionFriday, March 24, 2023 | 1:00 – 4:00 pm Becoming an Expert: Board Certification Support Series: Present the partnership between the SGO Taskforce for Board Certification Support and the American Board of Obstetrics and Gynecology (ABOG) to demystify the logistics of the gynecologic oncology subspecialty certifying exam and the assessment and scoring process. Overview with ABOG: 1 hour and 30 minutesStatistics Overview: 30 minutes  Three-day SGO Taskforce for Board Certification Support Roundtable Discussions – Part 1-3 | (7:15-8:15am)Target Audience: Candidates Taking Boards in April 2023The three-day roundtable will include discussions from taskforce facilitators covering hypothetical cases and case reviews with candidates that are in line with the sections of the certifying exam.Saturday March 25, 2023:  Ovarian, Peritoneal, Fallopian Tube Cancer (including Chemotherapy)]Sunday March 26, 2023: Uterine Malignancies: Endometrial Cancer, Sarcoma, GTD, otherMonday March 27, 2023: Cervical, Vulvar and Vaginal Cancer and Radiation TherapyResourcesClick here to access SGO ConnectEd to review additional resources on Ovarian Cancer.Review NCCN guidelines, UpToDate, and GYOEDU.ORG.Listen to Key Concepts of Enhanced Recovery After Surgery. ERAS–Why Do We Do It? There are SGO ConnectEd chemo flash cards that are high yield when it comes to toxicities. Special thanks to Drs. Beavis and Neff for your contribution to this episode.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

FDA D.I.S.C.O. Burst Edition: FDA approval of Elahere (mirvetuximab soravtansine-gynx) for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal cancer

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Jorge Hoegl to discuss peritoneal carcinomatosis after minimally invasive surgery in cervical cancer. Dr. Jorge Hoegl is an early career gynecologic oncologist at the Department of Obstetrics and Gynecology at the General Hospital of the East “Dr. Domingo Luciani” in Caracas, Venezuela. Highlights: -Peritoneal carcinomatosis represented more than 15% of all recurrences, with a recurrence rate of 22.2% in minimally invasive surgery compared to 8.8%. -Peritoneal carcinomatosis has been frequently grouped within distant recurrences and perhaps this made it not such a notorious fact. -Peritoneal carcinomatosis does not appear to be an unusual recurrence pattern associated with cervical cancer and it should be reported separately.

Join the #1 community of nursing students on the planet with 12,000+ students studying now inside of the NCLEX Virtual Trainer review on sale now at http://www.ReMarNurse.com   Your NCLEX RN & LPN Study Tools:  ► Get NCLEX Virtual Trainer: http://www.ReMarNurse.com/NCLEXVT ► Get the Question Bank: http://www.ReMarNurse.com/NCLEXQBank ► Get Quick Facts for NCLEX: http://bit.ly/QuickFactsNCLEX Get MORE from Regina MSN, RN: ► WATCH MORE: http://bit.ly/PassNCLEXPlayList/ ► GET THE PODCAST: https://remarnurse.podbean.com/ ► WATCH LESSONS: http://bit.ly/ReMarNCLEXLectures/ ► FOLLOW ReMar on Instagram: https://www.instagram.com/ReMarNurse/ ► LIKE ReMar on Facebook: https://www.facebook.com/ReMarReview/   ReMar Review features weekly NCLEX review questions and lectures from Regina M. Callion MSN, RN.  ReMar is the #1 content-based NCLEX review and has helped thousands of repeat-testers pass NCLEX with a 99.2% student success rate!   ReMar focuses on 100% core nursing content and as a result, has the best review to help nursing students pass boards - fast!

Contributor: Aaron Lessen, MD Educational Pearls: Patients with recurrent ascites may need frequent outpatient or emergency department paracentesis which can be time consuming and uncomfortable for patients.  Tunneled peritoneal catheters are a permanent alternative therapy which allows fluid drainage at home by patient or caregiver.  There has been theoretical concern that long term placement of tunneled peritoneal catheters may increase risk of infection, thus they are more commonly placed as a palliative measure for patients with end stage cancer and malignant ascites with shorter anticipated life spans. However, a recent small study found that in both patients with malignant ascites and recurrent ascites from cirrhosis, tunneled peritoneal catheter placement reduced symptoms from ascites and did not increase risk of infection or leakage at catheter site, or spontaneous bacterial peritonitis after four weeks. More research is emerging and tunneled peritoneal catheters may become more common.   References Kimer N, Riedel AN, Hobolth L, et al. Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series. Medicina (Kaunas). 2020;56(11):565. Published 2020 Oct 27. doi:10.3390/medicina56110565Petzold G, Bremer SCB, Heuschert FC, et al. Tunnelled Peritoneal Catheter for Malignant Ascites-An Open-Label, Prospective, Observational Trial. Cancers (Basel). 2021;13(12):2926. Published 2021 Jun 11. doi:10.3390/cancers13122926Corrigan M, Thomas R, McDonagh J, et al. Tunnelled peritoneal drainage catheter placement for the palliative management of refractory ascites in patients with liver cirrhosis. Frontline Gastroenterol. 2020;12(2):108-112. Published 2020 Feb 28. doi:10.1136/flgastro-2019-101332   Summarized by Kirsten Hughes, MS4 | Edited by John Spartz, MD & Erik Verzemnieks, MD   The Emergency Medical Minute is excited to announce that we are now offering AMA PRA Category 1 credits™ via online course modules. To access these and for more information, visit our website at https://emergencymedicalminute.org/cme-courses/ and create an account.  Donate to EMM today!

Rick Greene, MD, Alexandra Gangi, MD, and Rupen Shah, MD, discuss the landmark articles on which management of primary appendiceal peritoneal surface malignancies are based. Drs. Gangi and Shah are authors of, “The Landmark Series: Appendiceal Primary Peritoneal Surface Malignancy." Dr. Gangi is Director or the Gastrointestinal Tumor and Cancer Regional Therapies Programs, and Associate Program Director, Complex General Surgical Oncology Program, Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA. Dr. Rupen Shah is Director, Peritoneal Surface Malignancy Program and senior staff surgical oncologist at the Henry Ford Cancer Institute, Detroit, MI.

Meet Brit Mckoy and her amazing story, single mom of 2 boys yeah 2 freakin boys both under 4! Plus doing dialysis Brit Mckoy needs a kidney!! Go join her page and help her put!! https://www.facebook.com/KidneyForBrit/ Michael's movie review he reviews the movies we saw this week. We also have Christina's crazy corner!! This segment is her just having a blast with her friends talking about some fun information. Let's us know what you like and what we should do to make it better!! Please follow and share! #nxstage #livingondialysis #homehemodialysis #Gilchrist #gym #fistula #warriors #blindchick #renal #homehemodialysis #gym #graft #bruised #christinagilchrist #christina #michael #thecaretaker #dialysiswarrorblindchick #blindchick #blind #living!! #camping #fire #dialysiswarrior #fistula #graft #moviereview join our Facebook group! https://www.facebook.com/groups/1937182836456431/ --- Send in a voice message: https://podcasters.spotify.com/pod/show/blindchickliving/message

Take Home Points Think about causes – is it the head, the belly, or something else leading to the vomiting Get a upreg on all females of childbearing age Peritoneal signs – look for rebound/guarding, consider surgery consult prior to imaging if unstable Ask about last BM and if their passing gas – avoid metoclopramide ... Read more The post REBEL Core Cast – Basics of EM – Vomiting appeared first on REBEL EM - Emergency Medicine Blog.

Dr. Gwendalyn Randolph is the Emil R. Unanue Distinguished Professor in the Department of Immunology and Pathology at Washington University in St. Louis. Research in her lab integrates the study of monocytes, monocyte-derived cells, and dendritic cells with vascular and lymphatic vessel biology. She discusses the work she's presenting at the American Association of Immunologists' annual meeting, IMMUNOLOGY2022, on the diversity, function, and mysteries of peritoneal macrophages. 

We are joined by Dr. Aaron Mansfield of the Mayo Clinic to discuss a new, now enrolling, clinical trial for peritoneal mesothelioma that randomizes patients into two arms: an arm that receives chemotherapy + bevacizumab, and an arm that receives chemotherapy, bevacizumab and immunotherapy.